EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Exploring the Role of Long Non-Coding RNAs in Mediating Cisplatin Resistance in Glioma/Glioblastoma Cells

Hadi Sahrai, Reza Mosaddeghi-Heris iD, Nasrin Forghani iD, Ali Norouzi, Sahand Zare iD, Hamed Aghazadeh iD, Kimia Bagheri iD, Rebecca Kocsis, Firoz Ahmed iD, Niloofar Taheri iD, Shahab Uddin iD, Maryam Farzaneh iD

International Journal of Molecular Sciences · 04.07.2026 · 27 (13) · 6010

DOI: 10.3390/ijms27136010 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 04.07.2026. Verfasst von Hadi Sahrai und 11 weiteren Autor:innen. Beteiligte Einrichtung: Research Center for Evidence-Based Medicine, Iranian EBM Centre: A JBI Centre of Excellence, Faculty of Medicine, Tabriz University of Medical Scienc…. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Drug Resistance, Neoplasm, Cisplatin, Glioma. Die Arbeit nennt 159 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Malignant gliomas are highly aggressive primary brain tumors for which the therapeutic efficacy of cisplatin is frequently limited by intrinsic or acquired drug resistance. Despite advances in adjuvant therapies, overcoming chemoresistance remains a major challenge in the treatment of these malignancies. Emerging evidence indicates that long non-coding RNAs (lncRNAs), a class of non-protein-coding transcripts involved in gene regulation, play important roles in modulating treatment responses. Several lncRNAs, including differentiation antagonizing non-protein-coding RNA (DANCR), HOXD antisense growth-associated long non-coding RNA (HOXD-AS1), MEG3, MALAT1, and HOTAIR, have been implicated in pathways associated with glioma progression and therapeutic resistance. In particular, DANCR has been reported to promote cisplatin resistance in glioma cells through suppression of apoptosis and activation of pro-survival signaling pathways. This review summarizes current evidence regarding the roles of lncRNAs in cisplatin resistance, highlighting mechanisms such as regulation of drug transport, DNA damage repair, apoptosis, cancer stem-cell maintenance, and signaling pathways associated with treatment adaptation. We also discuss current limitations, challenges for clinical translation, and gaps in the existing evidence. A better understanding of lncRNA-mediated resistance mechanisms may facilitate the identification of novel therapeutic targets and inform future studies aimed at overcoming cisplatin resistance in malignant gliomas.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Long NoncodingDrug Resistance, NeoplasmCisplatinGliomaBrain NeoplasmsGlioblastomaHumansGene Expression Regulation, NeoplasticAntineoplastic AgentsAnimalsApoptosisSignal Transduction

Stichwörter der Autor:innen

apoptosiscisplatingliomaslncRNAsresistance

Substanzen

RNA, Long NoncodingCisplatinAntineoplastic Agents

Autor:innen und Institutionen

  • Research Center for Evidence-Based Medicine, Iranian EBM Centre: A JBI Centre of Excellence, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz 5166614711, Iran.
  • Neurosciences Research Center (NSRC), Tabriz University of Medical Sciences, Tabriz 5166614711, Iran.
  • Student Research Committee, Tabriz University of Medical Sciences, Tabriz 5166614711, Iran.
  • Clinical Research Development Unit of Tabriz Valiasr Hospital, Tabriz 5166614711, Iran.
  • Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran 1417614411, Iran.
  • Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz 5166614711, Iran.

ORCID-Profile: Reza Mosaddeghi-Heris, Nasrin Forghani, Sahand Zare, Hamed Aghazadeh, Kimia Bagheri, Firoz Ahmed, Niloofar Taheri, Shahab Uddin, Maryam Farzaneh

Zitieren

APA

Sahrai, H., Mosaddeghi-Heris, R., Forghani, N., Norouzi, A., Zare, S., Aghazadeh, H., Bagheri, K., Kocsis, R., Ahmed, F., Taheri, N., Uddin, S., & Farzaneh, M. (2026). Exploring the Role of Long Non-Coding RNAs in Mediating Cisplatin Resistance in Glioma/Glioblastoma Cells. International Journal of Molecular Sciences, 27(13), 6010. https://doi.org/10.3390/ijms27136010

Vancouver

Sahrai H, Mosaddeghi-Heris R, Forghani N, Norouzi A, Zare S, Aghazadeh H, et al. Exploring the Role of Long Non-Coding RNAs in Mediating Cisplatin Resistance in Glioma/Glioblastoma Cells. International Journal of Molecular Sciences. 2026;27(13):6010. doi:10.3390/ijms27136010

BibTeX
@article{Sahrai2026,
  author = {Sahrai, Hadi and Mosaddeghi-Heris, Reza and Forghani, Nasrin and Norouzi, Ali and Zare, Sahand and Aghazadeh, Hamed and Bagheri, Kimia and Kocsis, Rebecca and Ahmed, Firoz and Taheri, Niloofar and Uddin, Shahab and Farzaneh, Maryam},
  title = {Exploring the Role of Long Non-Coding RNAs in Mediating Cisplatin Resistance in Glioma/Glioblastoma Cells},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {13},
  pages = {6010},
  doi = {10.3390/ijms27136010}
}
Kostenlos starten →